Drug intelligence / Profile preview

124i-hua33

Development stage
Unknown
Lead developer
Memorial Sloan Kettering Cancer Center
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Monoclonal Antibodies → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

124I-huA33 is a radiolabeled, humanized monoclonal antibody designed for PET imaging of colorectal cancer. The huA33 antibody specifically targets the A33 antigen, which is expressed in more than 95% of colorectal cancers and in normal bowel tissue. By labeling huA33 with the positron-emitting isotope iodine-124 (124I), this agent enables quantitative PET imaging to assess tumor targeting, biodistribution, and safety in patients with primary or metastatic colorectal cancer. Clinical studies have shown that 124I-huA33 localizes effectively to tumors expressing the A33 antigen and demonstrates favorable pharmacokinetics without significant toxicity or acute side effects. Its uptake correlates directly with A33 antigen concentration in tissues[1][2][3][6].

Other names
Radiolabelled-huA33 (colorectal cancer)Anticancer monoclonal antibody A33huA33 antibodyhuA-33 antibodyhuA 33 antibody
02

Targets

GPA33 (Glycoprotein A33)

Beyond the preview

Go deeper on 124i-hua33.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 124i-hua33.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call